Scriba Nanotecnologie

Indirizzo: Via di Corticella, 183, 40128
Bologna BO
Telefono: 051 415 9501

ULTRAPLACAD

2015-2018

Ultrasensitive Plasmonic Devices for Early Cancer Diagnosis

ULTRAPLACAD aims at the development of a novel robust in vitro diagnostic system for early cancer diagnosis, prognosis, patient follow-up and therapy efficacy assessment based on molecular analysis of peripheral blood (liquid biopsy).

Scriba Nanotecnologie SRL

Via di Corticella 183/8 - 40128 Bologna (IT)
+39 051 4159501
info@scriba-nanotec.com

P.IVA IT02542781204
REA: 447542